We tested for tumor markers and found the squamous cell carcinoma (SCC) antigen was slightly elevated at 3.3 ng/mL, but the carcinoembryonic antigen (CEA) and CA 19–9 were within the reference range. The gene discussed is CEACAM5; the disease is squamous cell carcinoma.